Actelion Pharmaceuticals Us
UEI: H5BMHLMMNA28
• CAGE: 33TN9
Overview
Parent Awardee
Name
Actelion Pharmaceuticals Us
Headquarters
Titusville, NJ
United States
United States
Most Recent Award
May 1, 2025
Calculating
Federal contract recipient
ACTELION PHARMACEUTICALS US, INC.
(UEI H5BMHLMMNA28, CAGE 33TN9)
is headquartered in Titusville NJ.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in May 1998 and
federally registered in
November 2004.
Federal Award Analysis
Actelion Pharmaceuticals Us federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ACTELION PHARMACEUTICALS US, INC.
UEI
H5BMHLMMNA28
CAGE Code
33TN9
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
May 29, 1998
Initial Registration
Nov. 18, 2004
Last Registration
Dec. 4, 2024
Registration Activation
Dec. 4, 2024
Registration Expiration
Dec. 2, 2025
Fiscal Year End
December 29
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Accepts Credit Cards
No
People
Vendor contacts at Actelion Pharmaceuticals Us
GSA Schedules and Price Lists
- Actelion Pharmaceuticals Us
- PoP: 7/31/24 - 7/31/29
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $1,082,647
- Actelion Pharmaceuticals Us
- PoP: 5/14/19 - 7/31/24 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $11,289,537